Insider Transactions in Q1 2026 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2026
|
Andrew Callos EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-22.92%
|
$900,000
$60.28 P/Share
|
|
Jan 05
2026
|
Andrew Callos EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+18.65%
|
$345,000
$23.26 P/Share
|
|
Jan 02
2026
|
Andrew Callos EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,798
-1.75%
|
$111,476
$62.63 P/Share
|
|
Jan 02
2026
|
Andrew Callos EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
885
+1.7%
|
$32,745
$37.63 P/Share
|